CD8A and cancer: Reports of a positive association between higher predicted neoantigen load and increased intratumoral lymphocyte infiltration (CD3+ and CD8+ T cells) and improved overall survival in colorectal, endometrial and ovarian cancer (169–171) led to studies addressing the relationship between neoantigen abundance and success of immune checkpoint blockade therapy in cancer.